Heska Stock Forecast, Price & News

Heska (NASDAQ:HSKA) Frequently Asked Questions

Is Heska a buy right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Heska in the last twelve months. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Heska stock.
View analyst ratings for Heska or view top-rated stocks.

How has Heska's stock been impacted by Coronavirus (COVID-19)?

Heska's stock was trading at $81.83 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, HSKA shares have increased by 113.3% and is now trading at $174.52.
View which stocks have been most impacted by COVID-19.

When is Heska's next earnings date?

Heska is scheduled to release its next quarterly earnings announcement on Tuesday, February 22nd 2022.
View our earnings forecast for Heska.

How were Heska's earnings last quarter?

Heska Co. (NASDAQ:HSKA) issued its earnings results on Thursday, November, 4th. The medical research company reported ($0.19) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $0.04 by $0.23. The medical research company earned $60.24 million during the quarter, compared to analysts' expectations of $63.80 million. Heska had a net margin of 0.75% and a trailing twelve-month return on equity of 1.07%. The company's quarterly revenue was up 6.4% on a year-over-year basis. During the same period in the prior year, the firm posted ($0.25) EPS.
View Heska's earnings history.

What price target have analysts set for HSKA?

6 brokerages have issued twelve-month price targets for Heska's stock. Their forecasts range from $190.00 to $310.00. On average, they expect Heska's share price to reach $250.83 in the next twelve months. This suggests a possible upside of 43.7% from the stock's current price.
View analysts' price targets for Heska or view top-rated stocks among Wall Street analysts.

Who are Heska's key executives?

Heska's management team includes the following people:

• Kevin S. Wilson, President, Chief Executive Officer & Director (LinkedIn Profile)
• Nancy Wisnewski, Chief Operating Officer & Executive Vice President
• Catherine I. Grassman, Chief Financial Officer & Executive Vice President (LinkedIn Profile)
• Glenn R. Frank, Vice President-Research & Development
• Steven M. Eyl, Chief Commercial Officer & Executive VP

What is Kevin S. Wilson's approval rating as Heska's CEO?

5 employees have rated Heska CEO Kevin S. Wilson on Glassdoor.com. Kevin S. Wilson has an approval rating of 57% among Heska's employees. This puts Kevin S. Wilson in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Heska's key competitors?

Some companies that are related to Heska include Quidel (QDEL), Neogen (NEOG), Ortho Clinical Diagnostics (OCDX), Myriad Genetics (MYGN), Lantheus (LNTH), Celldex Therapeutics (CLDX), Meridian Bioscience (VIVO), Alpha Teknova (TKNO), MyMD Pharmaceuticals (MYMD), OncoCyte (OCX), Quotient (QTNT), Lucira Health (LHDX), Aspira Women's Health (AWH), VolitionRx (VNRX) and Nymox Pharmaceutical (NYMX).
View all of HSKA's competitors.

What other stocks do shareholders of Heska own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Heska investors own include Gilead Sciences (GILD), Exxon Mobil (XOM), Netflix (NFLX), Biogen (BIIB), AbbVie (ABBV), Amgen (AMGN), Broadcom (AVGO), Alibaba Group (BABA), Exelixis (EXEL) and Merck & Co., Inc. (MRK).

What is Heska's stock symbol?

Heska trades on the NASDAQ under the ticker symbol "HSKA."

Who are Heska's major shareholders?

Heska's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (16.98%), Invesco Ltd. (2.24%), Dimensional Fund Advisors LP (2.21%), Allianz Asset Management GmbH (1.79%), Geode Capital Management LLC (1.60%) and Thornburg Investment Management Inc. (1.51%). Company insiders that own Heska stock include Bonnie J Trowbridge, Catherine Grassman, Jason D Aroesty, Kevin S Wilson, Nancy Wisnewski and Sharon J Larson.
View institutional ownership trends for Heska.

Which institutional investors are selling Heska stock?

HSKA stock was sold by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Assenagon Asset Management S.A., Point72 Asset Management L.P., Manning & Napier Group LLC, Russell Investments Group Ltd., Thornburg Investment Management Inc., Morgan Stanley, and EAM Investors LLC. Company insiders that have sold Heska company stock in the last year include Catherine Grassman, Nancy Wisnewski, and Sharon J Larson.
View insider buying and selling activity for Heska or view top insider-selling stocks.

Which institutional investors are buying Heska stock?

HSKA stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Bares Capital Management Inc., Allianz Asset Management GmbH, Granahan Investment Management Inc. MA, SG Capital Management LLC, Millennium Management LLC, State of New Jersey Common Pension Fund D, and M&G Investment Management Ltd..
View insider buying and selling activity for Heska or or view top insider-buying stocks.

How do I buy shares of Heska?

Shares of HSKA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Heska's stock price today?

One share of HSKA stock can currently be purchased for approximately $174.52.

How much money does Heska make?

Heska has a market capitalization of $1.87 billion and generates $197.32 million in revenue each year. The medical research company earns $-14.40 million in net income (profit) each year or $0.19 on an earnings per share basis.

How many employees does Heska have?

Heska employs 602 workers across the globe.

What is Heska's official website?

The official website for Heska is www.heska.com.

Where are Heska's headquarters?

Heska is headquartered at 3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO, 80538.

How can I contact Heska?

Heska's mailing address is 3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO, 80538. The medical research company can be reached via phone at (970) 493-7272, via email at [email protected], or via fax at 970-619-3003.